Vancouver, Canada

Jaclyn Chau

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Abbvie Inc.. Active years: 2017-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jaclyn Chau. Retrieved from https://idiyas.com/inventor/jaclyn-chau

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 15.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Jaclyn Chau

Introduction: Jaclyn Chau is a prolific inventor based in Vancouver, Canada, known for his groundbreaking work in developing anti-viral compounds to combat Hepatitis C virus.

Latest Patents: Jaclyn Chau's latest patents focus on anti-viral compounds designed to inhibit the activity of the Hepatitis C virus polymerase. These compounds have shown great promise in treating HCV infections.

Career Highlights: Jaclyn Chau is associated with AbbVie Inc., a renowned pharmaceutical company known for its innovative approach to drug discovery and development.

Collaborations: Chau has collaborated closely with colleagues such as Hui-Ju J Chen and David A DeGoey, pooling their expertise to advance the field of antiviral drug development.

Conclusion: Jaclyn Chau's contributions to the field of anti-viral compounds mark him as a standout inventor in the fight against Hepatitis C virus. His work continues to pave the way for novel treatments and advancements in antiviral therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…